EU pharmaceutical expenditure forecast

Article English OPEN
Urbinati, Duccio; Rémuzat, Cécile; Kornfeld, Åsa; Vataire, Anne-Lise; Cetinsoy, Laurent; Aballéa, Samuel; Mzoughi, Olfa; Toumi, Mondher;
(2014)
  • Publisher: Journal of Market Access & Health Policy
  • Journal: Journal of Market Access & Health Policy,volume 2 (eissn: 2001-6689)
  • Related identifiers: doi: 10.3402/jmahp.v2.23738, pmc: PMC4865779
  • Subject: health policy | forecast model | Original Research Article | pharmaceutical expenditure | innovative medicine | generic | biosimilar
    mesheuropmc: health care economics and organizations

Background and Objectives: With constant incentives for healthcare payers to contain their pharmaceutical budgets, forecasting has become critically important. Some countries have, for instance, developed pharmaceutical horizon scanning units. The objective of this proj... View more
  • References (15)
    15 references, page 1 of 2

    1. IMS Health (2012). The global use of medicines: Outlook through 2016. Available from: http://www.imshealth.com/ deployedfiles/ims/Global/Content/Insights/IMS Institute for Healthcare Informatics/Global Use of Meds 2011/Medicines_ Outlook_Through_2016_Report.pdf [cited 10 October 2013].

    2. Datamonitor (2012). Branded prescription pharmaceutical sales outlook to 2016. Report Ref: HC00229-001. Available from: https:// service.datamonitorhealthcare.com/ [cited 10 October 2013].

    3. Eurostat (2012). Population structure and ageing. Available from: http://epp.eurostat.ec.europa.eu/statistics_explained/index. php/Population_structure_and_ageing [cited 10 October 2013].

    4. European Directive 2010/84/EU of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Available from: http://ec.europa.eu/health/files/eudralex/ vol-1/dir_2010_84/dir_2010_84_en.pdf [cited 10 October 2013].

    5. Health Policy Advisory Committee on Technology (HealthPACT) website. Available from: http://www.health.qld.gov.au/ healthpact/default.asp [cited 10 October 2013].

    6. NIHR Horizon Scanning Centre website. Available from: http://www.hsc.nihr.ac.uk/about-us/ [cited 10 October 2013].

    7. European Medicines Agency. Central authorization of medicines. Available from: http://www.ema.europa.eu/ema/index. jsp?curl pages/about_us/general/general_content_000109.jsp [cited 10 October 2013].

    8. European Commission (2012). The 2012 ageing reporteconomic and budgetary projection for the 27 EU Member States (2010 2060). European Economy 2. Available from: http://ec.europa.eu/economy_finance/publications/european_ economy/2012/pdf/ee-2012-2_en.pdf [cited 10 October 2013].

    9. Vataire A-L, Cetinsoy L, Aballe´a S, Re´muzat C, Urbinati D, Kornfeld A˚ , et al. Novel methodology for pharmaceutical expenditure forecast. J Market Access Health Policy 2014:2, http://dx.doi.org/10.3402/jmahp.v2.24082

    10. Datamonitor (2011). Biosimilars: Pipeline trends. Report Ref: HC00149-002. Available from: https://service.datamonitorhealth care.com/ [cited 10 October 2013].

  • Metrics
    No metrics available
Share - Bookmark